SCHH vs XBI

Schwab US REIT ETF vs SPDR S&P Biotech ETF

Quick take
  • SCHH has the lower expense ratio at 0.07% vs 0.35% for XBI.
  • SCHH pays a higher dividend yield (2.79%).

Side-by-side metrics

MetricSCHHXBI
Expense ratio
Annual fee. Lower is better.
0.07%0.35%
Dividend yield
Trailing 12-month yield.
2.79%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$11.13B$10.73B
YTD return
15.26%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.981.10
P/E ratio
30.40
Last price
$23.91$164.01
Inception
Issuer
SchwabState Street

SCHH top holdings

Top holdings · SCHH
WELLWelltower Inc10.35%
PLDPrologis Inc8.34%
SPGSimon Property Group Inc4.78%
EQIXEquinix Inc4.30%
DLRDigital Realty Trust Inc4.30%
ORealty Income Corp4.02%
AMTAmerican Tower Corp3.95%
PSAPublic Storage3.50%
VTRVentas Inc2.97%
IRMIron Mountain Inc2.64%
Sector breakdown · SCHH
Real Estate100.0%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About SCHH

SCHH (Schwab US REIT ETF) is US REITs at very low cost. Managed by Schwab, the fund carries $11.1B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.79%. Its largest holding is Welltower Inc (WELL), which represents 10.3% of the portfolio. Real Estate is the fund's largest sector exposure at 100.0%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.